Insights

More Articles Back to Article

Indian vaccine manufacturer predicts lengthy shortage

Adar Poonawalla, chief executive of India's Serum Institute, expects vaccines to be in short supply for several months as Indian health officials grapple with a rise in new cases. Pfizer is asking the Indian government to expedite approval of its vaccine developed with BioNTech. Reuters (5/3)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!